Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KETOBHB-BA is a patented exogenous ketone supplement developed to enhance both mental and physical performance. Its primary active ingredient is beta-hydroxybutyrate (BHB) in a unique formulation designed to support ketosis without inhibiting the body's own ketone production (ketogenesis). The product also includes electrolytes for improved hydration and muscle function. Mechanistically, it provides an alternative energy substrate for the brain and muscles during periods of low carbohydrate intake or fasting by elevating circulating ketone levels. Reported benefits include enhanced cognitive clarity, increased endurance during exercise, reduced inflammation, improved blood sugar regulation, cardiovascular support, and positive effects on the gut microbiome through short-chain fatty acid production. It is marketed as a dietary supplement for weight management and metabolic health[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on KETOBHB-BA.